{"gene":"RAB9A","run_date":"2026-06-10T06:43:36","timeline":{"discoveries":[{"year":1993,"finding":"Rab9 localizes primarily to the surface of late endosomes and, when prenylated in vitro, stimulates transport of mannose 6-phosphate receptors (MPRs) from late endosomes to the trans-Golgi network (TGN) in a cell-free reconstitution assay. C-terminally truncated Rab9 (unable to be prenylated) was inactive, and Rab7 (also on late endosomes) was inactive in this assay despite efficient prenylation and GTP binding/hydrolysis.","method":"In vitro prenylation assay, cell-free transport reconstitution, subcellular localization","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — cell-free reconstitution with prenylated recombinant protein, functional mutagenesis (C-terminal truncation), and specificity controls (Rab7 inactive); foundational paper replicated extensively","pmids":["8440258"],"is_preprint":false},{"year":1993,"finding":"Rab9 hydrolyzes GTP with a rate constant of 0.0052 min⁻¹ at 37°C; GDP and GTP each dissociate from Rab9 with first-order rate constants of 0.017 min⁻¹. Second-order association rate constants for GDP and GTP binding to nucleotide-free Rab9 were 1.7×10⁶ M⁻¹s⁻¹ and 1.2×10⁵ M⁻¹s⁻¹, respectively.","method":"In vitro GTP hydrolysis assay, nucleotide binding kinetics with purified recombinant Rab9","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro enzymatic characterization with purified recombinant protein and defined kinetic parameters","pmids":["8463223"],"is_preprint":false},{"year":1993,"finding":"Cytosolic Rab9 exists as an equimolar complex with a GDI-like protein (~80 kDa). Complex formation requires intact Rab9 C-terminus and geranylgeranylation; monoprenylation is sufficient. Purified Rab3A-GDI can solubilize Rab9-GDP, but not Rab9-GTP, from cytoplasmic membranes, supporting a model in which GDI recycles Rab9 from target membranes after a catalytic transport cycle.","method":"In vitro reconstitution of GDI-Rab9 complex, geranylgeranylation assay, membrane extraction assay","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with recombinant proteins, C-terminal mutant controls, nucleotide-state specificity demonstrated","pmids":["8389620"],"is_preprint":false},{"year":1994,"finding":"Dominant-negative Rab9(S21N) expressed in living cells strongly inhibits MPR recycling to the TGN, reduces lysosomal enzyme sorting efficiency, and causes compensatory upregulation of lysosomal enzyme synthesis—demonstrating that Rab9 GTPase activity is required for MPR recycling and efficient lysosomal biogenesis in vivo.","method":"Dominant-negative mutant overexpression in cells, pulse-chase lysosomal enzyme sorting assay, fluid-phase and receptor-mediated endocytosis controls","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean dominant-negative loss-of-function with specific phenotypic readout and multiple controls ruling off-target effects; widely replicated","pmids":["7909812"],"is_preprint":false},{"year":1994,"finding":"Selective membrane targeting of prenylated Rab9 onto late endosome membranes is reconstituted in vitro and is accompanied by endosome-triggered nucleotide exchange (GDP→GTP). This establishes that late endosomes provide a guanine nucleotide exchange activity that activates Rab9 upon membrane delivery.","method":"In vitro membrane recruitment assay with prenylated Rab9-GDI complexes, nucleotide exchange measurement","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution of selective targeting with nucleotide exchange measurement; published in Nature with rigorous biochemical controls","pmids":["8164745"],"is_preprint":false},{"year":1994,"finding":"GDI-bound Rab9 (Rab9-GDI complex) represents a functional cytosolic pool that supports late endosome-to-TGN transport in vitro. GDI increases the efficiency of Rab9 utilization by suppressing mistargeting; GDI itself inhibits transport by sequestering Rab9 from membranes. Rab7 and Rab9 use biochemically distinct recruitment machineries on late endosome membranes.","method":"Immunodepletion of cytosolic GDI-Rab9, reconstitution with purified Rab9-GDI, competitive inhibition experiments","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — immunodepletion and reconstitution with purified components, competitive inhibition with defined Km/Ki values","pmids":["8195183","7592724"],"is_preprint":false},{"year":1997,"finding":"p40 (a 40 kDa protein) is a Rab9-GTP-preferential effector identified by yeast two-hybrid; it does not interact with Rab7 or K-Ras. Purified recombinant p40 potently stimulates MPR transport from endosomes to TGN in vitro, anti-p40 antibodies inhibit transport, and p40 shows synergy with Rab9—consistent with p40 and Rab9 acting together to drive transport vesicle docking.","method":"Yeast two-hybrid, GST pulldown, in vitro transport assay with recombinant p40, antibody inhibition","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (two-hybrid, pulldown, reconstituted transport, antibody inhibition) in one study","pmids":["9230071"],"is_preprint":false},{"year":2001,"finding":"The cargo adaptor TIP47 binds directly to GTP-bound (active) Rab9 GTPase. Rab9-GTP binding increases the affinity of TIP47 for MPR cytoplasmic domains. A functional Rab9-binding site in TIP47 is required for TIP47 stimulation of MPR transport in vivo, establishing that Rab9 recruits TIP47 onto late endosomes and couples vesicle budding to active GTPase.","method":"Direct binding assay (in vitro), TIP47-MPR affinity measurement, dominant-negative Rab9 binding-site mutant rescue in cells","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro binding, quantitative affinity measurements, and functional validation in cells with binding-site mutant","pmids":["11359012"],"is_preprint":false},{"year":2002,"finding":"GFP-Rab9 localizes to late endosomes and occupies a distinct microdomain from Rab7 on the same late endosome membrane; CI-MPRs are enriched in the Rab9 domain. Live-cell video microscopy shows Rab9-positive transport vesicles (not tubules) fusing with the TGN; Rab9 remains vesicle-associated until membrane fusion and is rapidly removed upon docking/fusion.","method":"Live-cell fluorescence microscopy (GFP variants), video microscopy of vesicle fusion events","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — live imaging with direct visualization of fusion events; multiple fluorescent markers; widely cited","pmids":["11827983"],"is_preprint":false},{"year":2002,"finding":"TIP47 residues 161–169 are essential (but not sufficient) for Rab9 binding. Mutation of these residues markedly decreases Rab9 binding without altering global protein folding or the ability of TIP47 to bind MPR cytoplasmic domains, demonstrating distinct binding domains for Rab9 and MPR in TIP47.","method":"Site-directed mutagenesis, binding assay, circular dichroism, partial proteolysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis with multiple orthogonal structural and functional validations","pmids":["12032303"],"is_preprint":false},{"year":2003,"finding":"The lipid kinase PIKfyve physically interacts with the Rab9 effector p40 via its chaperonin domain and p40's kelch repeats (determined by yeast two-hybrid, GST pulldown, and co-IP). Kinase-dead PIKfyve causes depletion of p40 from membrane fractions. PIKfyve phosphorylates p40 on serine in vitro, and this phosphorylation correlates with p40 membrane association, suggesting PIKfyve-catalyzed phosphorylation anchors p40 to membranes to facilitate late endosome-to-TGN transport.","method":"Yeast two-hybrid, GST pulldown, co-immunoprecipitation, differential centrifugation, in vitro kinase assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal binding methods plus in vitro kinase assay in one study","pmids":["14530284"],"is_preprint":false},{"year":2004,"finding":"Rab9 depletion by siRNA decreases late endosome size, reduces multilamellar and dense-tubule-containing late endosomes/lysosomes, causes perinuclear clustering of remaining organelles, and leads to increased surface MPRs and lysosome-associated membrane protein 1, with MPR missorting to lysosomes. Rab9 stability on late endosomes requires interaction with TIP47 (its effector), revealing that effector interaction maintains Rab membrane residence.","method":"siRNA knockdown, immunofluorescence, endosome morphology analysis, MPR trafficking assay","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KD with multiple defined phenotypic readouts and mechanistic follow-up on effector-dependent stability","pmids":["15456905"],"is_preprint":false},{"year":2006,"finding":"BLOC-3 (HPS1-HPS4 heterodimer) interacts specifically and strongly with GTP-bound Rab9 via the HPS4 subunit engaging the switch I and II regions of Rab9, identifying BLOC-3 as a Rab9 effector.","method":"Recombinant protein co-expression in insect cells, analytical ultracentrifugation, GST pulldown interaction screen, deletion analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — recombinant reconstitution, analytical ultracentrifugation, and interaction mapping with switch-region specificity","pmids":["20048159"],"is_preprint":false},{"year":2006,"finding":"TIP47 is a key determinant of Rab9 localization: changing cellular concentrations of TIP47 (a Rab9 effector) can redirect Rab5/9 and Rab1/9 chimeras from their parental Rab localizations toward late endosomes. This demonstrates that effector concentrations compete to determine Rab localization.","method":"Chimeric Rab GTPase expression, effector binding quantification, live-cell localization assay","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — chimera approach with quantified effector binding and direct localization readout; multiple Rab chimeras tested","pmids":["16769818"],"is_preprint":false},{"year":2006,"finding":"Cholesterol accumulation in Niemann-Pick type C (NPC) cells elevates Rab9 protein levels (1.8-fold) by reducing its turnover and stabilizes Rab9 on endosome membranes, impairing GDI-mediated extraction. Cholesterol directly stabilizes prenylated Rab9 on liposomes in proportion to cholesterol content, sequestering Rab9 in an inactive form and disrupting CI-MPR recycling. Overexpression of GFP-Rab9 reverses MPR missorting in NPC cells.","method":"Western blot, half-life assay, GDI extraction assay, cholesterol-loaded liposome binding assay, siRNA knockdown to model NPC, GFP-Rab9 rescue","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — direct biochemical liposome assay plus cell biological assays with rescue experiment; multiple orthogonal methods","pmids":["16644737"],"is_preprint":false},{"year":2011,"finding":"RUTBC1 contains a TBC domain and binds specifically to Rab9A-GTP (in vitro and in cells) but is not a GAP for Rab9A. Instead, RUTBC1 is a GAP for Rab32 and Rab33B (requiring Arg-803 as the catalytic arginine finger, consistent with a dual-finger mechanism). Rab9A binding does not influence RUTBC1 GAP activity, but RUTBC1 influences Rab32's ability to bind its effector Varp, consistent with RUTBC1 linking Rab9A and Rab32 in adjacent pathways at late endosomes.","method":"In vitro GTP hydrolysis screen of Rab substrates, site-directed mutagenesis of catalytic Arg, co-immunoprecipitation, cell extract effector-binding assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — biochemical screen with mutagenesis, catalytic mechanism tested, cellular validation with effector-binding assay","pmids":["21808068"],"is_preprint":false},{"year":2011,"finding":"Furin transits early and late endosomes en route to the TGN and requires Rab9 and the golgin GCC185 for efficient TGN retrieval from late endosomes. TGN38 trafficking is independent of Rab9. Furin-TGN38 chimera experiments show that both the transmembrane domain and cytoplasmic tail of TGN38 are required to divert furin from the Rab9-dependent late endosome pathway to the retromer-dependent early endosome pathway; transmembrane domain length contributes to endosomal sorting.","method":"Internalization assay, dominant-negative Rab9, siRNA knockdown of GCC185, chimeric protein expression","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two orthogonal loss-of-function approaches (dominant-negative and siRNA) with chimera dissection in single lab","pmids":["21693586"],"is_preprint":false},{"year":2012,"finding":"RUTBC2 (TBC domain protein) binds Rab9A-GTP specifically in vitro and in cells but is not a GAP for Rab9A. RUTBC2 is a GAP for Rab34 and Rab36 (highest activity toward Rab36), requiring Arg-829 for catalysis. In cells, RUTBC2 co-localizes with Rab36 and decreases membrane-associated Rab36, linking Rab9A function to Rab36 in the endosomal system.","method":"Rab substrate GAP screen in vitro, site-directed mutagenesis, co-immunoprecipitation, co-localization, membrane fractionation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — biochemical GAP screen, catalytic mutagenesis, and cellular validation with membrane fractionation","pmids":["22637480"],"is_preprint":false},{"year":2013,"finding":"In Drosophila trachea, Rab9 together with retromer (Vps35) and WASH regulates selective retrograde recycling of the luminal protein Serpentine from late endosomes. Vps35, WASH, and actin filaments differentially localize to Rab9-enriched subdomains of the endosomal membrane, where Serpentine-containing vesicles bud. Loss of Rab9, Vps35, or WASH depletes luminal Serpentine at later stages (without affecting initial secretion), causing excessively elongated tubes.","method":"Genetic mutant analysis (Rab9, Vps35, WASH loss-of-function in Drosophila), immunofluorescence co-localization, tube length phenotype quantification","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple independent genetic mutants with specific phenotypic readout and protein co-localization in Drosophila","pmids":["23322046"],"is_preprint":false},{"year":2016,"finding":"Live-cell imaging shows Rab9 constitutively active mutant (Rab9Q66L) localizes predominantly to late endosomes and disperses TGN46 and CI-MPR from the Golgi, but does not block retrograde transport of CI-MPR. Rab9 and CI-MPR enter the endosomal pathway together at the early-to-late endosome transition stage (between Rab5-positive and Rab7a-positive compartments); CI-MPR-containing vesicles attach and detach within seconds from distinct endosomal domains.","method":"Confocal live-cell imaging, constitutively active mutant expression (Rab9Q66L), co-localization with Rab5/Rab7a markers","journal":"Traffic","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — live imaging with constitutively active mutant, single lab, two orthogonal approaches","pmids":["26663757"],"is_preprint":false},{"year":2019,"finding":"During myocardial ischemia, mitophagy is mediated predominantly by Rab9-associated autophagosomes rather than the canonical ATG7/LC3 conjugation system. A protein complex of Ulk1, Rab9, Rip1, and Drp1 mediates recruitment of trans-Golgi membranes to damaged mitochondria. Ulk1 phosphorylates Rab9 at Ser179; knockin of Rab9(S179A) abolishes this alternative mitophagy and exacerbates ischemic injury without affecting conventional autophagy.","method":"Co-immunoprecipitation, knockin mouse (Rab9 S179A), cardiac ischemia model, mitophagy flux assay, ATG7-deficient controls","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — knockin mouse with phospho-site mutation, co-IP of complex, multiple pathway controls (ATG7-deficient); in vivo ischemia model","pmids":["30511961"],"is_preprint":false},{"year":2009,"finding":"Rab9 interacts with the intermediate filament protein vimentin. In NPC1 cells, lipid accumulation inhibits PKC, causing hypophosphorylation of vimentin, which leads to vimentin aggregation and Rab9 entrapment within the aggregates, thereby disrupting late endosome function and lipid egress.","method":"Co-immunoprecipitation, PKC inhibition assay, vimentin phosphorylation analysis, Rab9-vimentin interaction assay in NPC1 cells","journal":"Biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — co-IP and mechanistic follow-up in NPC1 cells, single lab","pmids":["18681838"],"is_preprint":false},{"year":2010,"finding":"Rab9 co-localizes in vesicular structures with TRPC6 and co-immunoprecipitates with TRPC6. Dominant-negative Rab9(S21N) increases TRPC6 at the plasma membrane and augments TRPC6-mediated Ca²⁺ entry upon muscarinic stimulation, demonstrating that Rab9-dependent late endosomal trafficking regulates TRPC6 surface density.","method":"Co-immunoprecipitation, confocal co-localization, dominant-negative Rab9 expression, Ca²⁺ imaging","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — co-IP plus functional dominant-negative phenotype; single lab, single study","pmids":["20346379"],"is_preprint":false},{"year":2021,"finding":"Nde1 (and its paralog Ndel1) is a Rab9A effector: GTP-bound Rab9A specifically interacts with Nde1/Ndel1 to link late endosomes to the cytoplasmic dynein motor complex. Crystal structure of Rab9A-GTP bound to the Rab9-binding region of Nde1 was determined. Key interface residues verified by mutagenesis; Rab9A mutants unable to bind Nde1 failed to associate with dynein, Lis1, and dynactin, establishing Nde1 as the tether between Rab9-positive late endosomes and dynein for retrograde transport.","method":"Crystal structure determination, biochemical pulldown, mutagenesis of interface residues, co-immunoprecipitation in cells","journal":"Structure","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with functional validation by mutagenesis and cell biology assays","pmids":["34793709"],"is_preprint":false},{"year":2021,"finding":"In asthma, IL-4 activates a ULK1/Atg9a/Rab9 signaling cascade: ULK1 phosphorylates Atg9a at Ser14; Atg9a is a superior upstream regulator of Rab9; and Rab9 plays a role in inflammation-induced Golgi apparatus fragmentation. Inhibition of ULK1/Atg9a/Rab9 reduces Golgi fragmentation and mitochondrial oxidative stress.","method":"ULK1 knockout mice, lentiviral overexpression of ULK1 WT and S467A mutant in Beas-2b cells, co-IP (ULK1-Atg9a), phosphorylation site mutagenesis","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO plus phospho-site mutagenesis in cells; single lab, Rab9-specific evidence is downstream/indirect","pmids":["38373380"],"is_preprint":false},{"year":2023,"finding":"NDP52 forms a complex with Rab9 and HBV envelope proteins and links HBV to a Rab9-dependent lysosomal degradation pathway. This process is independent of galectin-8 and ATG5. Inactivating NDP52 reduces targeting of viral envelopes to lysosomes and increases viral replication levels.","method":"Co-immunoprecipitation (NDP52-Rab9-HBV envelope), NDP52 knockdown in hepatocytes, ATG5-independent pathway controls","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP with three-component complex, knockdown phenotype, pathway controls; single lab","pmids":["38114531"],"is_preprint":false},{"year":2023,"finding":"Rab9a in its GTP-bound form inhibits (rather than promotes) retromer-mediated endosomal exit of HPV during virus entry. Rab9a knockdown impairs retromer-mediated endosome-to-Golgi transport of HPV and causes HPV accumulation in endosomes. Excess GTP-Rab9a impairs HPV entry, whereas excess GDP-Rab9a reduces L2-Rab9a association and stimulates entry—a noncanonical action opposite to Rab9a's role for cellular cargo.","method":"siRNA knockdown, dominant-negative and constitutively active Rab9a overexpression, proximity ligation assay (Rab9a-HPV), retromer interaction assay","journal":"PLoS pathogens","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple Rab9a mutants plus knockdown with specific phenotypic and interaction readouts; single lab","pmids":["37703297"],"is_preprint":false},{"year":2024,"finding":"TMEM9, a lysosomal transmembrane protein, interacts with Beclin1 via its Bcl-2-binding domain to activate Rab9-dependent alternative autophagy. TMEM9-Beclin1 interaction dissociates Bcl-2 from Beclin1, enabling LC3-independent, Rab9-dependent autophagosome formation. TMEM9 colocalizes with Rab9 on late endosomes/lysosomes. Multiple glycosylation of TMEM9 (required for lysosomal localization) is essential for Beclin1 binding and Rab9-dependent autophagy activation.","method":"Co-immunoprecipitation (TMEM9-Beclin1), Bcl-2 dissociation assay, TMEM9 glycosylation mutants, autophagy flux assay, co-localization","journal":"Cellular and molecular life sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP with domain mapping, glycosylation mutant functional validation, autophagy readout; single lab","pmids":["39078420"],"is_preprint":false},{"year":2026,"finding":"GDP-bound Rab9a has an extremely short half-life compared with GTP-bound Rab9a and compared with the closely related Rab7. Hydrophobic residues exposed in the switch I region of GDP-Rab9a constitute a conformation-dependent hydrophobic (CDH) degron recognized by the protein quality control (PQC) machinery including valosin-containing protein/p97. CDH degron-mutated Rab9a accumulates in cells and causes defective CI-M6PR localization; forced accumulation phenocopies PQC dysfunction.","method":"Half-life measurement, site-directed mutagenesis of switch I hydrophobic residues, CI-M6PR localization assay, identification of p97 as CDH degron reader","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — mutagenesis with functional readout and identification of PQC factor; single lab, recent publication","pmids":["41628772"],"is_preprint":false},{"year":2017,"finding":"Pharmacological PKC activation promotes α1B-adrenergic receptor transfer to late endosomes (Rab9-positive compartment) following early endosome transit (Rab5). Dominant-negative Rab9-GDP abolishes receptor traffic to late endosomes, alters desensitization of the calcium response, and suppresses receptor internalization, identifying Rab9-mediated late endosome trafficking as a component of heterologous adrenergic receptor desensitization.","method":"FRET (DsRed-α1B-AR / EGFP-Rab proteins), confocal microscopy, dominant-negative Rab9 expression, intracellular Ca²⁺ quantitation, PKC inhibitors","journal":"Molecular pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — FRET-based interaction in live cells plus functional Ca²⁺ readout with dominant-negative validation; single lab","pmids":["28082304"],"is_preprint":false},{"year":2019,"finding":"HPS4 Rab32/38-GEF activity (not its Rab9-binding activity) is essential for melanogenesis in HPS4-deficient melanocytes. Re-expression of an HPS4 mutant specifically lacking Rab9-binding activity fully rescues pigmentation and tyrosinase trafficking, whereas Rab32/38-GEF-deficient HPS4 fails to rescue. This demonstrates that the Rab9-BLOC-3 interaction is dispensable for melanogenesis.","method":"Site-directed mutagenesis of HPS4 (separate Rab32/38-GEF-null and Rab9-binding-null mutants), rescue assay in melan-le HPS4-deficient melanocytes, melanin content and tyrosinase trafficking assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — separation-of-function mutagenesis with two distinct mutants, clean rescue assay in disease-relevant cell line","pmids":["30837268"],"is_preprint":false},{"year":2024,"finding":"RAB9 protein levels increase significantly in aged (old) oocytes in humans and mice. RAB9 localizes to the meiotic spindle periphery and cortex. Rab9 overexpression disrupts spindle formation, chromosome alignment, actin cap formation, cortical actin levels, increases ROS, decreases mitochondrial membrane potential and ATP, and activates PINK1-PARKIN mitophagy. Reducing RAB9 expression in old oocytes partially improves maturation rate, reduces ROS and spindle abnormalities.","method":"Immunofluorescence (localization in oocytes), Rab9 overexpression and knockdown, mitochondrial function assays, ROS measurement, PINK1/PARKIN pathway analysis","journal":"Aging cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function with multiple quantitative readouts in oocytes; single lab, single study","pmids":["39676221"],"is_preprint":false}],"current_model":"RAB9A is a late-endosomal Rab GTPase that, in its active GTP-bound state, recruits the cargo adaptor TIP47 (with enhanced affinity for MPR cytoplasmic tails) and the effector p40 onto a distinct subdomain of late endosomes to drive transport vesicle budding and docking at the TGN for recycling of mannose 6-phosphate receptors; GDI delivers prenylated Rab9-GDP to late endosomes where nucleotide exchange activates it, and after fusion, GDI extracts Rab9-GDP for cytosolic recycling. Additional effectors include Nde1/Ndel1 (tethering Rab9-positive late endosomes to the dynein motor for retrograde transport), RUTBC1 (a Rab9A-GTP-binding Rab32/33B-GAP linking Rab9A to lysosome-related organelle pathways), RUTBC2 (a Rab9A-GTP-binding Rab36-GAP), and BLOC-3/HPS4 (whose Rab9 interaction is dispensable for melanogenesis). A functionally distinct role has been established in alternative (non-canonical, ATG7/LC3-independent) autophagy: a complex of Ulk1, Rab9, Rip1, and Drp1 mediates mitophagy through Ulk1 phosphorylation of Rab9 at Ser179, which recruits trans-Golgi membranes to damaged mitochondria, and this pathway is cardioprotective under ischemia. GDP-bound Rab9a is rapidly degraded via a conformation-dependent hydrophobic degron in its switch I region recognized by p97/VCP quality-control machinery, ensuring proper CI-M6PR trafficking."},"narrative":{"mechanistic_narrative":"RAB9A is a late-endosomal Rab GTPase that drives retrograde recycling of mannose 6-phosphate receptors (MPRs) from late endosomes to the trans-Golgi network, a transport step required for efficient lysosomal enzyme sorting and lysosomal biogenesis [PMID:8440258, PMID:7909812]. Cycling between GDP- and GTP-bound states (with defined intrinsic hydrolysis and nucleotide-exchange kinetics) governs its activity [PMID:8463223]: GDI delivers prenylated Rab9-GDP to late endosomes, where an endosome-associated exchange activity converts it to the active GTP form and GDI then extracts Rab9-GDP for cytosolic recycling [PMID:8389620, PMID:8164745, PMID:8195183, PMID:7592724]. On late endosomes Rab9 occupies a distinct microdomain separate from Rab7, enriched in CI-MPR, from which Rab9-positive vesicles bud and fuse with the TGN [PMID:11827983]. In its GTP-bound state Rab9 recruits a set of effectors that execute transport: the cargo adaptor TIP47, whose Rab9 binding enhances its affinity for MPR cytoplasmic tails and couples cargo capture to the active GTPase, and the effector p40, which synergizes with Rab9 to stimulate transport and is anchored to membranes by PIKfyve-catalyzed phosphorylation [PMID:9230071, PMID:11359012, PMID:12032303, PMID:14530284]; effector occupancy in turn stabilizes Rab9 on the membrane and dictates its localization [PMID:15456905, PMID:16769818]. Additional GTP-dependent effectors connect Rab9 to other organelle pathways and the cytoskeleton: Nde1/Ndel1 tethers Rab9-positive late endosomes to the dynein motor for retrograde transport (defined by crystal structure) [PMID:34793709], while the TBC-domain proteins RUTBC1 and RUTBC2 bind Rab9A-GTP yet act as GAPs for Rab32/Rab33B and Rab34/Rab36 respectively, linking Rab9 to adjacent Rab pathways [PMID:21808068, PMID:22637480]. BLOC-3 (HPS1-HPS4) is a GTP-dependent Rab9 effector, but this interaction is dispensable for melanogenesis [PMID:20048159, PMID:30837268]. Distinct from its trafficking role, Rab9 mediates an ATG7/LC3-independent alternative autophagy in which a Ulk1-Rab9-Rip1-Drp1 complex, dependent on Ulk1 phosphorylation of Rab9 at Ser179, recruits trans-Golgi membranes to damaged mitochondria and is cardioprotective during ischemia [PMID:30511961]. Rab9 dysfunction is mechanistically tied to Niemann-Pick type C, where cholesterol stabilizes inactive Rab9 on membranes and impairs MPR recycling [PMID:16644737]. The GDP-bound state is intrinsically unstable, exposing a conformation-dependent hydrophobic degron in switch I recognized by the p97/VCP quality-control machinery, which couples Rab9a turnover to correct CI-M6PR trafficking [PMID:41628772].","teleology":[{"year":1993,"claim":"Established Rab9 as a functionally specific, prenylation-dependent regulator of late endosome-to-TGN transport of MPRs, distinct from the co-resident Rab7.","evidence":"Cell-free transport reconstitution with prenylated recombinant Rab9, C-terminal truncation mutant, and Rab7 specificity control","pmids":["8440258"],"confidence":"High","gaps":["Effectors mediating the transport step not yet identified","Mechanism of selective late-endosome targeting unresolved"]},{"year":1993,"claim":"Defined the intrinsic enzymatic parameters of Rab9, quantifying its slow GTP hydrolysis and nucleotide exchange rates as the kinetic basis for its GTPase switch.","evidence":"In vitro GTP hydrolysis and nucleotide binding kinetics with purified recombinant Rab9","pmids":["8463223"],"confidence":"High","gaps":["No GAP or GEF identified at this stage","Does not connect kinetics to in vivo regulation"]},{"year":1993,"claim":"Showed Rab9 cycles through a cytosolic GDI-bound, GDP-state pool, defining how the prenylated GTPase is solubilized and recycled in a nucleotide-state-dependent manner.","evidence":"In vitro reconstitution of GDI-Rab9 complex with geranylgeranylation and membrane extraction assays","pmids":["8389620"],"confidence":"High","gaps":["Identity of the membrane GEF not established","Spatial coupling of extraction to transport cycle not resolved"]},{"year":1994,"claim":"Demonstrated in living cells that Rab9 GTPase activity is required for MPR recycling and lysosomal biogenesis, validating in vitro findings physiologically.","evidence":"Dominant-negative Rab9(S21N) overexpression with pulse-chase lysosomal enzyme sorting assays","pmids":["7909812"],"confidence":"High","gaps":["Dominant-negative may sequester shared GEFs","Direct effectors still unknown"]},{"year":1994,"claim":"Resolved the activation and recruitment cycle by showing late endosomes provide GEF activity that activates GDI-delivered Rab9 upon selective membrane targeting.","evidence":"In vitro reconstitution of prenylated Rab9-GDI membrane recruitment with nucleotide exchange measurement; immunodepletion/reconstitution of cytosolic GDI-Rab9","pmids":["8164745","8195183","7592724"],"confidence":"High","gaps":["Molecular identity of the late-endosomal GEF not determined","Determinants of Rab9-vs-Rab7 recruitment specificity not defined"]},{"year":1997,"claim":"Identified p40 as the first GTP-preferential Rab9 effector that synergizes with Rab9 to drive transport vesicle docking.","evidence":"Yeast two-hybrid, GST pulldown, reconstituted transport assay, and antibody inhibition with recombinant p40","pmids":["9230071"],"confidence":"High","gaps":["Membrane recruitment mechanism of p40 not yet defined","Structural basis of Rab9-p40 interaction unknown"]},{"year":2001,"claim":"Established the cargo-coupling mechanism: Rab9-GTP recruits TIP47 and increases its affinity for MPR tails, linking active GTPase to cargo capture and vesicle budding.","evidence":"Direct in vitro binding, TIP47-MPR affinity measurement, and Rab9-binding-site mutant rescue in cells","pmids":["11359012"],"confidence":"High","gaps":["Coordination between TIP47 and p40 not resolved","Structural details of the Rab9-TIP47 interface not yet defined"]},{"year":2002,"claim":"Mapped the discrete TIP47 region required for Rab9 binding and showed it is separate from the MPR-binding domain, defining bipartite cargo-adaptor architecture.","evidence":"Site-directed mutagenesis with circular dichroism and partial proteolysis controls","pmids":["12032303"],"confidence":"High","gaps":["Residues necessary but not sufficient — full binding determinants incomplete"]},{"year":2002,"claim":"Visualized Rab9 as a discrete late-endosome microdomain enriched in CI-MPR from which transport vesicles bud and fuse with the TGN, defining the spatial organization of the pathway.","evidence":"Live-cell and video fluorescence microscopy with GFP-Rab9 and multiple markers","pmids":["11827983"],"confidence":"High","gaps":["Mechanism establishing the Rab9/Rab7 domain boundary unknown","Fusion machinery at the TGN not defined"]},{"year":2003,"claim":"Connected lipid kinase signaling to the pathway by showing PIKfyve phosphorylates the effector p40 to anchor it to membranes.","evidence":"Yeast two-hybrid, GST pulldown, co-IP, fractionation, and in vitro kinase assay with kinase-dead PIKfyve","pmids":["14530284"],"confidence":"High","gaps":["Phosphosite on p40 not mapped","Direct effect on Rab9 itself not demonstrated"]},{"year":2004,"claim":"Showed effector binding reciprocally stabilizes Rab9 on membranes and defined the cellular consequences of Rab9 loss for endosome morphology and MPR sorting.","evidence":"siRNA knockdown with endosome morphology and MPR trafficking readouts","pmids":["15456905"],"confidence":"High","gaps":["Mechanism by which TIP47 stabilizes Rab9 not biochemically defined"]},{"year":2006,"claim":"Expanded the Rab9 effector repertoire to BLOC-3 and demonstrated that effector concentration competes to determine Rab9 subcellular localization.","evidence":"Recombinant reconstitution, analytical ultracentrifugation, switch-region mapping; Rab chimera localization with quantified effector binding","pmids":["20048159","16769818"],"confidence":"High","gaps":["Functional role of Rab9-BLOC-3 interaction not yet defined","How competing effectors are spatially regulated unknown"]},{"year":2006,"claim":"Provided a mechanistic link between Rab9 and Niemann-Pick type C, showing cholesterol stabilizes inactive Rab9 and impairs MPR recycling, reversible by Rab9 overexpression.","evidence":"Half-life and GDI-extraction assays, cholesterol-loaded liposome binding, NPC siRNA model, GFP-Rab9 rescue","pmids":["16644737"],"confidence":"High","gaps":["Direct molecular interaction of cholesterol with Rab9 not structurally defined"]},{"year":2009,"claim":"Linked Rab9 to the cytoskeleton via vimentin and proposed a route by which lipid accumulation entraps Rab9 in NPC1 cells.","evidence":"Co-IP, PKC inhibition, vimentin phosphorylation analysis in NPC1 cells","pmids":["18681838"],"confidence":"Medium","gaps":["Single-lab co-IP without structural mapping","Functional consequence of Rab9-vimentin binding for normal trafficking unclear"]},{"year":2010,"claim":"Extended Rab9-dependent late-endosomal trafficking to control of a plasma-membrane channel, TRPC6, and downstream Ca2+ entry.","evidence":"Co-IP, co-localization, dominant-negative Rab9, Ca2+ imaging","pmids":["20346379"],"confidence":"Medium","gaps":["Single study","Direct vs indirect Rab9-TRPC6 interaction not resolved"]},{"year":2011,"claim":"Identified RUTBC1 as a Rab9A-GTP-binding TBC protein that is a GAP not for Rab9 but for Rab32/Rab33B, positioning Rab9A as an organizer linking adjacent Rab pathways at late endosomes.","evidence":"In vitro GAP substrate screen, catalytic Arg mutagenesis, co-IP, effector-binding assay","pmids":["21808068"],"confidence":"High","gaps":["Biological significance of Rab9A-RUTBC1 coupling in cells not fully established"]},{"year":2011,"claim":"Defined cargo specificity of the Rab9 pathway by showing furin requires Rab9 and GCC185 for TGN retrieval whereas TGN38 does not, mapping the determinants that route cargo into the Rab9-dependent route.","evidence":"Dominant-negative Rab9, GCC185 siRNA, furin-TGN38 chimera dissection","pmids":["21693586"],"confidence":"Medium","gaps":["Single-lab study","Sorting determinant mechanism only partially resolved"]},{"year":2012,"claim":"Identified RUTBC2 as a second Rab9A-GTP-binding TBC protein acting as a GAP for Rab34/Rab36, reinforcing Rab9A as a hub connecting distinct Rab modules.","evidence":"In vitro GAP screen, catalytic mutagenesis, co-IP, co-localization, membrane fractionation","pmids":["22637480"],"confidence":"High","gaps":["Physiological pathway connecting Rab9A and Rab36 not defined"]},{"year":2013,"claim":"Showed in vivo (Drosophila) that Rab9 cooperates with retromer and WASH at endosomal subdomains for selective retrograde recycling, broadening its role beyond MPRs.","evidence":"Genetic loss-of-function of Rab9, Vps35, WASH; co-localization; tube-length phenotypes","pmids":["23322046"],"confidence":"High","gaps":["Direct biochemical link between Rab9 and retromer/WASH not established"]},{"year":2016,"claim":"Refined the timing of Rab9/CI-MPR entry into the endosomal pathway and showed constitutively active Rab9 disperses TGN markers without blocking retrograde transport.","evidence":"Confocal live-cell imaging with Rab9Q66L and Rab5/Rab7a co-localization","pmids":["26663757"],"confidence":"Medium","gaps":["Single lab","Mechanism of TGN marker dispersal unresolved"]},{"year":2017,"claim":"Implicated Rab9-dependent late-endosomal trafficking in heterologous desensitization of the α1B-adrenergic receptor.","evidence":"FRET, confocal microscopy, dominant-negative Rab9, Ca2+ quantitation, PKC inhibitors","pmids":["28082304"],"confidence":"Medium","gaps":["Single study","Direct Rab9-receptor interaction not demonstrated"]},{"year":2019,"claim":"Established a distinct, non-canonical function for Rab9 in ATG7/LC3-independent alternative mitophagy via a Ulk1-Rab9-Rip1-Drp1 complex driven by Ser179 phosphorylation, with cardioprotective consequences.","evidence":"Co-IP, Rab9(S179A) knockin mouse, cardiac ischemia model, ATG7-deficient controls","pmids":["30511961"],"confidence":"High","gaps":["How phospho-Rab9 recruits trans-Golgi membranes mechanistically unclear","Relationship to canonical Rab9 trafficking function not resolved"]},{"year":2019,"claim":"Separated the GEF and Rab9-binding functions of HPS4, demonstrating that the Rab9-BLOC-3 interaction is dispensable for melanogenesis.","evidence":"Separation-of-function HPS4 mutants, rescue in HPS4-deficient melanocytes, melanin/tyrosinase readouts","pmids":["30837268"],"confidence":"High","gaps":["Physiological role of the Rab9-BLOC-3 interaction remains undefined"]},{"year":2021,"claim":"Determined the structural and functional basis for Rab9A coupling to retrograde dynein transport via the effector Nde1/Ndel1.","evidence":"Crystal structure of Rab9A-GTP:Nde1, interface mutagenesis, co-IP showing loss of dynein/Lis1/dynactin association","pmids":["34793709"],"confidence":"High","gaps":["Coordination of Nde1 tethering with budding/fusion not defined"]},{"year":2021,"claim":"Placed Rab9 downstream of a ULK1/Atg9a cascade in inflammation-induced Golgi fragmentation in asthma.","evidence":"ULK1 KO mice, ULK1 WT/S467A overexpression, ULK1-Atg9a co-IP, phosphosite mutagenesis","pmids":["38373380"],"confidence":"Medium","gaps":["Rab9-specific evidence is downstream/indirect","Direct Rab9 regulatory mechanism not established"]},{"year":2023,"claim":"Revealed roles for Rab9 in host-pathogen interactions: NDP52-Rab9 directs HBV envelopes to lysosomal degradation, while Rab9a-GTP non-canonically inhibits retromer-mediated HPV endosomal exit.","evidence":"Co-IP of NDP52-Rab9-HBV envelope with knockdown; siRNA, dominant-negative/constitutively active Rab9a, PLA, retromer interaction assays for HPV","pmids":["38114531","37703297"],"confidence":"Medium","gaps":["Single-lab studies","Whether Rab9 directly binds viral components not resolved"]},{"year":2024,"claim":"Identified TMEM9 as an activator of Rab9-dependent alternative autophagy through Beclin1 engagement and Bcl-2 displacement.","evidence":"Co-IP, Bcl-2 dissociation assay, TMEM9 glycosylation mutants, autophagy flux, co-localization","pmids":["39078420"],"confidence":"Medium","gaps":["Single lab","Direct Rab9-TMEM9 functional coupling not biochemically defined"]},{"year":2024,"claim":"Linked elevated RAB9 to oocyte aging, where its overexpression disrupts spindle/actin organization and triggers PINK1-PARKIN mitophagy and oxidative stress.","evidence":"Immunofluorescence localization, Rab9 gain/loss-of-function, mitochondrial and ROS assays in human and mouse oocytes","pmids":["39676221"],"confidence":"Medium","gaps":["Single study","Causal mechanism connecting Rab9 to spindle/actin defects unresolved"]},{"year":2026,"claim":"Showed that the GDP-bound state of Rab9a is intrinsically unstable due to a switch-I conformation-dependent hydrophobic degron read by p97/VCP, coupling Rab9a turnover to correct CI-M6PR trafficking.","evidence":"Half-life measurement, switch-I hydrophobic-residue mutagenesis, CI-M6PR localization assay, identification of p97 as degron reader","pmids":["41628772"],"confidence":"Medium","gaps":["Single lab, recent","Full PQC machinery beyond p97 not defined","How degron sensing is balanced against GDI extraction unclear"]},{"year":null,"claim":"How Rab9 partitions between its canonical retrograde trafficking role and its non-canonical alternative-autophagy/host-defense roles, and what GEF activates it on late endosomes, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["Molecular identity of the late-endosomal Rab9 GEF unknown","Switch between trafficking and alternative-autophagy effector complexes not defined","Structural basis of phospho-Ser179 effector recruitment unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[1,3]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[7,11,15,17]}],"localization":[{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[0,8,11,19]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2,5]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[8,16]}],"pathway":[{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[0,3,7,8]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[6,23]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[20,27]}],"complexes":["Ulk1-Rab9-Rip1-Drp1 alternative-autophagy complex","BLOC-3 (HPS1-HPS4) effector complex"],"partners":["TIP47","P40","NDE1","NDEL1","RUTBC1","RUTBC2","HPS4","ULK1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P51151","full_name":"Ras-related protein Rab-9A","aliases":[],"length_aa":201,"mass_kda":22.8,"function":"The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. Rabs cycle between an inactive GDP-bound form and an active GTP-bound form that is able to recruit to membranes different sets of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion (By similarity). RAB9A is involved in the transport of proteins between the endosomes and the trans-Golgi network (TGN) (PubMed:34793709). Specifically uses NDE1/NDEL1 as an effector to interact with the dynein motor complex in order to control retrograde trafficking of RAB9-associated late endosomes to the TGN (PubMed:34793709). Involved in the recruitment of SGSM2 to melanosomes and is required for the proper trafficking of melanogenic enzymes TYR, TYRP1 and DCT/TYRP2 to melanosomes in melanocytes (By similarity)","subcellular_location":"Cell membrane; Endoplasmic reticulum membrane; Golgi apparatus membrane; Late endosome; Cytoplasmic vesicle, phagosome membrane; Cytoplasmic vesicle, phagosome; Cytoplasmic vesicle membrane; Melanosome","url":"https://www.uniprot.org/uniprotkb/P51151/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RAB9A","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000123595","cell_line_id":"CID000443","localizations":[{"compartment":"vesicles","grade":3},{"compartment":"cytoplasmic","grade":1},{"compartment":"er","grade":1}],"interactors":[{"gene":"CDX2","stoichiometry":0.2},{"gene":"GDI1","stoichiometry":0.2},{"gene":"GDI2","stoichiometry":0.2},{"gene":"ANKRD26","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000443","total_profiled":1310},"omim":[{"mim_id":"620120","title":"DENN DOMAIN-CONTAINING PROTEIN 2A; DENND2A","url":"https://www.omim.org/entry/620120"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Nucleoplasm","reliability":"Uncertain"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/RAB9A"},"hgnc":{"alias_symbol":[],"prev_symbol":["RAB9"]},"alphafold":{"accession":"P51151","domains":[{"cath_id":"3.40.50.300","chopping":"5-185","consensus_level":"high","plddt":95.4938,"start":5,"end":185}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P51151","model_url":"https://alphafold.ebi.ac.uk/files/AF-P51151-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P51151-F1-predicted_aligned_error_v6.png","plddt_mean":91.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RAB9A","jax_strain_url":"https://www.jax.org/strain/search?query=RAB9A"},"sequence":{"accession":"P51151","fasta_url":"https://rest.uniprot.org/uniprotkb/P51151.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P51151/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P51151"}},"corpus_meta":[{"pmid":"8440258","id":"PMC_8440258","title":"Rab9 functions in transport between late endosomes and the trans Golgi network.","date":"1993","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8440258","citation_count":484,"is_preprint":false},{"pmid":"7909812","id":"PMC_7909812","title":"Lysosome biogenesis requires Rab9 function and receptor recycling from endosomes to the trans-Golgi network.","date":"1994","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/7909812","citation_count":265,"is_preprint":false},{"pmid":"11827983","id":"PMC_11827983","title":"Visualization of Rab9-mediated vesicle transport from endosomes to the trans-Golgi in living cells.","date":"2002","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11827983","citation_count":243,"is_preprint":false},{"pmid":"30511961","id":"PMC_30511961","title":"An alternative mitophagy pathway mediated by Rab9 protects the heart against ischemia.","date":"2019","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/30511961","citation_count":230,"is_preprint":false},{"pmid":"11359012","id":"PMC_11359012","title":"Role of Rab9 GTPase in facilitating receptor recruitment by TIP47.","date":"2001","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11359012","citation_count":201,"is_preprint":false},{"pmid":"8164745","id":"PMC_8164745","title":"Membrane targeting of the small GTPase Rab9 is accompanied by nucleotide exchange.","date":"1994","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8164745","citation_count":172,"is_preprint":false},{"pmid":"8389620","id":"PMC_8389620","title":"Rab GDI: a solubilizing and recycling factor for rab9 protein.","date":"1993","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/8389620","citation_count":145,"is_preprint":false},{"pmid":"15456905","id":"PMC_15456905","title":"Rab9 GTPase regulates late endosome size and requires effector interaction for its stability.","date":"2004","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/15456905","citation_count":136,"is_preprint":false},{"pmid":"16140752","id":"PMC_16140752","title":"Rab9 GTPase is required for replication of human immunodeficiency virus type 1, filoviruses, and measles virus.","date":"2005","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/16140752","citation_count":128,"is_preprint":false},{"pmid":"9230071","id":"PMC_9230071","title":"A novel Rab9 effector required for endosome-to-TGN transport.","date":"1997","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9230071","citation_count":119,"is_preprint":false},{"pmid":"16644737","id":"PMC_16644737","title":"Cholesterol accumulation sequesters Rab9 and disrupts late endosome function in NPC1-deficient cells.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16644737","citation_count":101,"is_preprint":false},{"pmid":"16769818","id":"PMC_16769818","title":"TIP47 is a key effector for Rab9 localization.","date":"2006","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16769818","citation_count":83,"is_preprint":false},{"pmid":"12576506","id":"PMC_12576506","title":"Telomerase immortalization upregulates Rab9 expression and restores LDL cholesterol egress from Niemann-Pick C1 late endosomes.","date":"2002","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/12576506","citation_count":81,"is_preprint":false},{"pmid":"23322046","id":"PMC_23322046","title":"Rab9 and retromer regulate retrograde trafficking of luminal protein required for epithelial tube length control.","date":"2013","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/23322046","citation_count":78,"is_preprint":false},{"pmid":"22452336","id":"PMC_22452336","title":"The small GTPases Rab9A and Rab23 function at distinct steps in autophagy during Group A Streptococcus infection.","date":"2012","source":"Cellular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/22452336","citation_count":75,"is_preprint":false},{"pmid":"20048159","id":"PMC_20048159","title":"Assembly of the biogenesis of lysosome-related organelles complex-3 (BLOC-3) and its interaction with Rab9.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20048159","citation_count":73,"is_preprint":false},{"pmid":"11452006","id":"PMC_11452006","title":"Endosome to Golgi transport of ricin is independent of clathrin and of the Rab9- and Rab11-GTPases.","date":"2001","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/11452006","citation_count":71,"is_preprint":false},{"pmid":"8195183","id":"PMC_8195183","title":"Rab-GDI presents functional Rab9 to the intracellular transport machinery and contributes selectivity to Rab9 membrane recruitment.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8195183","citation_count":69,"is_preprint":false},{"pmid":"15972801","id":"PMC_15972801","title":"Protein transduction of Rab9 in Niemann-Pick C cells reduces cholesterol storage.","date":"2005","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/15972801","citation_count":69,"is_preprint":false},{"pmid":"7592724","id":"PMC_7592724","title":"Rab7 and Rab9 are recruited onto late endosomes by biochemically distinguishable processes.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7592724","citation_count":63,"is_preprint":false},{"pmid":"21693586","id":"PMC_21693586","title":"Rab9-dependent retrograde transport and endosomal sorting of the endopeptidase furin.","date":"2011","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/21693586","citation_count":57,"is_preprint":false},{"pmid":"14530284","id":"PMC_14530284","title":"Active PIKfyve associates with and promotes the membrane attachment of the late endosome-to-trans-Golgi network transport factor Rab9 effector p40.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14530284","citation_count":56,"is_preprint":false},{"pmid":"21808068","id":"PMC_21808068","title":"RUTBC1 protein, a Rab9A effector that activates GTP hydrolysis by Rab32 and Rab33B proteins.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21808068","citation_count":53,"is_preprint":false},{"pmid":"18681838","id":"PMC_18681838","title":"Endosomal lipid accumulation in NPC1 leads to inhibition of PKC, hypophosphorylation of vimentin and Rab9 entrapment.","date":"2009","source":"Biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/18681838","citation_count":48,"is_preprint":false},{"pmid":"24480419","id":"PMC_24480419","title":"TIP47 is associated with the hepatitis C virus and its interaction with Rab9 is required for release of viral particles.","date":"2013","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/24480419","citation_count":44,"is_preprint":false},{"pmid":"33719502","id":"PMC_33719502","title":"Estrogen Plays a Crucial Role in Rab9-Dependent Mitochondrial Autophagy, Delaying Arterial Senescence.","date":"2021","source":"Journal of the American Heart Association","url":"https://pubmed.ncbi.nlm.nih.gov/33719502","citation_count":41,"is_preprint":false},{"pmid":"8463223","id":"PMC_8463223","title":"Biochemical analysis of rab9, a ras-like GTPase involved in protein transport from late endosomes to the trans Golgi network.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8463223","citation_count":39,"is_preprint":false},{"pmid":"27574541","id":"PMC_27574541","title":"The multiple roles of Rab9 in the endolysosomal system.","date":"2016","source":"Communicative & integrative biology","url":"https://pubmed.ncbi.nlm.nih.gov/27574541","citation_count":38,"is_preprint":false},{"pmid":"30889053","id":"PMC_30889053","title":"Long noncoding RNA ZFAS1 promotes tumorigenesis through regulation of miR-150-5p/RAB9A in melanoma.","date":"2019","source":"Melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/30889053","citation_count":36,"is_preprint":false},{"pmid":"19056848","id":"PMC_19056848","title":"Development of a Rab9 transgenic mouse and its ability to increase the lifespan of a murine model of Niemann-Pick type C disease.","date":"2008","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/19056848","citation_count":35,"is_preprint":false},{"pmid":"21829543","id":"PMC_21829543","title":"Cellular vacuoles induced by Mycoplasma pneumoniae CARDS toxin originate from Rab9-associated compartments.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21829543","citation_count":33,"is_preprint":false},{"pmid":"26663757","id":"PMC_26663757","title":"Spatiotemporal Resolution of Rab9 and CI-MPR Dynamics in the Endocytic Pathway.","date":"2016","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/26663757","citation_count":32,"is_preprint":false},{"pmid":"29574782","id":"PMC_29574782","title":"Rab9-dependent autophagy is required for the IGF-IIR triggering mitophagy to eliminate damaged mitochondria.","date":"2018","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29574782","citation_count":31,"is_preprint":false},{"pmid":"22637480","id":"PMC_22637480","title":"RUTBC2 protein, a Rab9A effector and GTPase-activating protein for Rab36.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22637480","citation_count":30,"is_preprint":false},{"pmid":"12032303","id":"PMC_12032303","title":"Identification of residues in TIP47 essential for Rab9 binding.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12032303","citation_count":30,"is_preprint":false},{"pmid":"20346379","id":"PMC_20346379","title":"Involvement of Rab9 and Rab11 in the intracellular trafficking of TRPC6.","date":"2010","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/20346379","citation_count":28,"is_preprint":false},{"pmid":"19442299","id":"PMC_19442299","title":"Phylogeny and evolution of Rab7 and Rab9 proteins.","date":"2009","source":"BMC evolutionary biology","url":"https://pubmed.ncbi.nlm.nih.gov/19442299","citation_count":27,"is_preprint":false},{"pmid":"30837268","id":"PMC_30837268","title":"The BLOC-3 subunit HPS4 is required for activation of Rab32/38 GTPases in melanogenesis, but its Rab9 activity is dispensable for melanogenesis.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30837268","citation_count":27,"is_preprint":false},{"pmid":"19684018","id":"PMC_19684018","title":"Human copper transporter 1 lacking O-linked glycosylation is proteolytically cleaved in a Rab9-positive endosomal compartment.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19684018","citation_count":27,"is_preprint":false},{"pmid":"12154075","id":"PMC_12154075","title":"Selective regulation of the Rab9-independent transport of ricin to the Golgi apparatus by calcium.","date":"2002","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/12154075","citation_count":24,"is_preprint":false},{"pmid":"30667375","id":"PMC_30667375","title":"Ulk1/Rab9-mediated alternative mitophagy confers cardioprotection during energy stress.","date":"2019","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/30667375","citation_count":23,"is_preprint":false},{"pmid":"38373380","id":"PMC_38373380","title":"IL-4 activates ULK1/Atg9a/Rab9 in asthma, NLRP3 inflammasomes, and Golgi fragmentation by increasing autophagy flux and mitochondrial oxidative stress.","date":"2024","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/38373380","citation_count":22,"is_preprint":false},{"pmid":"33862456","id":"PMC_33862456","title":"Loss of androgen receptor promotes HCC invasion and metastasis via activating circ-LNPEP/miR-532-3p/RAB9A signal under hypoxia.","date":"2021","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/33862456","citation_count":22,"is_preprint":false},{"pmid":"9126495","id":"PMC_9126495","title":"Cloning and mapping of human Rab7 and Rab9 cDNA sequences and identification of a Rab9 pseudogene.","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9126495","citation_count":21,"is_preprint":false},{"pmid":"38164158","id":"PMC_38164158","title":"Selective induction of Rab9-dependent alternative mitophagy using a synthetic derivative of isoquinoline alleviates mitochondrial dysfunction and cognitive deficits in Alzheimer's disease models.","date":"2024","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/38164158","citation_count":19,"is_preprint":false},{"pmid":"31489965","id":"PMC_31489965","title":"Accumulation of sphingomyelin in Niemann-Pick disease type C cells disrupts Rab9-dependent vesicular trafficking of cholesterol.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31489965","citation_count":19,"is_preprint":false},{"pmid":"38114531","id":"PMC_38114531","title":"NDP52 mediates an antiviral response to hepatitis B virus infection through Rab9-dependent lysosomal degradation pathway.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38114531","citation_count":18,"is_preprint":false},{"pmid":"34610499","id":"PMC_34610499","title":"Rab9 Mediates Pancreatic Autophagy Switch From Canonical to Noncanonical, Aggravating Experimental Pancreatitis.","date":"2021","source":"Cellular and molecular gastroenterology and hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/34610499","citation_count":17,"is_preprint":false},{"pmid":"32420351","id":"PMC_32420351","title":"RAB9A Plays an Oncogenic Role in Human Liver Cancer Cells.","date":"2020","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/32420351","citation_count":15,"is_preprint":false},{"pmid":"28082304","id":"PMC_28082304","title":"Protein Kinase C Activation Promotes α1B-Adrenoceptor Internalization and Late Endosome Trafficking through Rab9 Interaction. Role in Heterologous Desensitization.","date":"2017","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28082304","citation_count":14,"is_preprint":false},{"pmid":"30881034","id":"PMC_30881034","title":"The overexpression of Rab9 promotes tumor progression regulated by XBP1 in breast cancer.","date":"2019","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30881034","citation_count":13,"is_preprint":false},{"pmid":"34793709","id":"PMC_34793709","title":"Nde1 is a Rab9 effector for loading late endosomes to cytoplasmic dynein motor complex.","date":"2021","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/34793709","citation_count":12,"is_preprint":false},{"pmid":"33968929","id":"PMC_33968929","title":"Circular RNA circSIPA1L1 Contributes to Osteosarcoma Progression Through the miR-411-5p/RAB9A Signaling Pathway.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/33968929","citation_count":11,"is_preprint":false},{"pmid":"39078420","id":"PMC_39078420","title":"TMEM9 activates Rab9-dependent alternative autophagy through interaction with Beclin1.","date":"2024","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/39078420","citation_count":10,"is_preprint":false},{"pmid":"32526284","id":"PMC_32526284","title":"Rab9 defense against white spot syndrome virus by participation in autophagy in Marsupenaeus japonicas.","date":"2020","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32526284","citation_count":9,"is_preprint":false},{"pmid":"37703297","id":"PMC_37703297","title":"Noncanonical Rab9a action supports retromer-mediated endosomal exit of human papillomavirus during virus entry.","date":"2023","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/37703297","citation_count":8,"is_preprint":false},{"pmid":"32301398","id":"PMC_32301398","title":"Knockdown of Rab9 Suppresses the Progression of Gastric Cancer Through Regulation of Akt Signaling Pathway.","date":"2020","source":"Technology in cancer research & treatment","url":"https://pubmed.ncbi.nlm.nih.gov/32301398","citation_count":8,"is_preprint":false},{"pmid":"11043518","id":"PMC_11043518","title":"cDNA cloning of a new member of the Ras superfamily, RAB9-like, on the human chromosome Xq22.1-q22.3 region.","date":"2000","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11043518","citation_count":8,"is_preprint":false},{"pmid":"33392103","id":"PMC_33392103","title":"VARP and Rab9 Are Dispensable for the Rab32/BLOC-3 Dependent Salmonella Killing.","date":"2020","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/33392103","citation_count":7,"is_preprint":false},{"pmid":"29499180","id":"PMC_29499180","title":"Modulation of cis- and trans- Golgi and the Rab9A-GTPase during infection by Besnoitia besnoiti, Toxoplasma gondii and Neospora caninum.","date":"2018","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/29499180","citation_count":7,"is_preprint":false},{"pmid":"16473602","id":"PMC_16473602","title":"Purification and analysis of TIP47 function in Rab9-dependent mannose 6-phosphate receptor trafficking.","date":"2005","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/16473602","citation_count":7,"is_preprint":false},{"pmid":"37020694","id":"PMC_37020694","title":"Isoliquiritigenin regulates the circ_0002860/miR-431-5p/RAB9A axis to function as a tumor inhibitor in melanoma.","date":"2023","source":"The journal of venomous animals and toxins including tropical diseases","url":"https://pubmed.ncbi.nlm.nih.gov/37020694","citation_count":5,"is_preprint":false},{"pmid":"34056112","id":"PMC_34056112","title":"Circ_0013359 facilitates the tumorigenicity of melanoma by regulating miR-136-5p/RAB9A axis.","date":"2021","source":"Open life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34056112","citation_count":5,"is_preprint":false},{"pmid":"16473631","id":"PMC_16473631","title":"Analysis of potential binding of the recombinant Rab9 effector p40 to phosphoinositide-enriched synthetic liposomes.","date":"2005","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/16473631","citation_count":5,"is_preprint":false},{"pmid":"39676221","id":"PMC_39676221","title":"Age-associated accumulation of RAB9 disrupts oocyte meiosis.","date":"2024","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/39676221","citation_count":3,"is_preprint":false},{"pmid":"37231931","id":"PMC_37231931","title":"Circ_0081054 facilitates melanoma development via sponging miR-637 and regulating RAB9A.","date":"2023","source":"Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)","url":"https://pubmed.ncbi.nlm.nih.gov/37231931","citation_count":3,"is_preprint":false},{"pmid":"41009712","id":"PMC_41009712","title":"The Role of the Beclin1 Complex in Rab9-Dependent Alternative Autophagy.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41009712","citation_count":3,"is_preprint":false},{"pmid":"38193389","id":"PMC_38193389","title":"The host Rab9a/Rab32 axis is actively recruited to the Trypanosoma cruzi parasitophorous vacuole and benefits the infection cycle.","date":"2024","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/38193389","citation_count":3,"is_preprint":false},{"pmid":"14993700","id":"PMC_14993700","title":"Purification, crystallization and preliminary X-ray analysis of the GTP-binding protein Rab9 implicated in endosome-to-TGN vesicle trafficking.","date":"2004","source":"Acta crystallographica. Section D, Biological crystallography","url":"https://pubmed.ncbi.nlm.nih.gov/14993700","citation_count":2,"is_preprint":false},{"pmid":"41628772","id":"PMC_41628772","title":"A conformation-dependent hydrophobic degron determines Rab9a-mediated vesicular trafficking.","date":"2026","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/41628772","citation_count":1,"is_preprint":false},{"pmid":"37205481","id":"PMC_37205481","title":"Noncanonical Rab9a action supports endosomal exit of human papillomavirus during virus entry.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/37205481","citation_count":0,"is_preprint":false},{"pmid":"39311306","id":"PMC_39311306","title":"Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells.","date":"2024","source":"Pathophysiology : the official journal of the International Society for Pathophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/39311306","citation_count":0,"is_preprint":false},{"pmid":"41930813","id":"PMC_41930813","title":"Dehydroandrographolide succinate alleviates ulcerative colitis via regulating RAB9A/NF-κB axis-mediated macrophage polarization and remodeling the gut microbiota.","date":"2026","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/41930813","citation_count":0,"is_preprint":false},{"pmid":"41274424","id":"PMC_41274424","title":"Disruption of Rab9-dependent mitophagy contributes to menopause-induced sarcopenia.","date":"2025","source":"Experimental gerontology","url":"https://pubmed.ncbi.nlm.nih.gov/41274424","citation_count":0,"is_preprint":false},{"pmid":"38752371","id":"PMC_38752371","title":"CALCOCO2/NDP52 associates with RAB9 to initiate an antiviral response to hepatitis B virus infection through a lysosomal degradation pathway.","date":"2024","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/38752371","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.12.13.628388","title":"Encephalomyocarditis virus non-structural protein 2C degrades NDP52 autophagy protein to promote its own survival","date":"2024-12-13","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.13.628388","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":38563,"output_tokens":9057,"usd":0.125772,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18705,"output_tokens":7839,"usd":0.14475,"stage2_stop_reason":"end_turn"},"total_usd":0.270522,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"Rab9 localizes primarily to the surface of late endosomes and, when prenylated in vitro, stimulates transport of mannose 6-phosphate receptors (MPRs) from late endosomes to the trans-Golgi network (TGN) in a cell-free reconstitution assay. C-terminally truncated Rab9 (unable to be prenylated) was inactive, and Rab7 (also on late endosomes) was inactive in this assay despite efficient prenylation and GTP binding/hydrolysis.\",\n      \"method\": \"In vitro prenylation assay, cell-free transport reconstitution, subcellular localization\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cell-free reconstitution with prenylated recombinant protein, functional mutagenesis (C-terminal truncation), and specificity controls (Rab7 inactive); foundational paper replicated extensively\",\n      \"pmids\": [\"8440258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Rab9 hydrolyzes GTP with a rate constant of 0.0052 min⁻¹ at 37°C; GDP and GTP each dissociate from Rab9 with first-order rate constants of 0.017 min⁻¹. Second-order association rate constants for GDP and GTP binding to nucleotide-free Rab9 were 1.7×10⁶ M⁻¹s⁻¹ and 1.2×10⁵ M⁻¹s⁻¹, respectively.\",\n      \"method\": \"In vitro GTP hydrolysis assay, nucleotide binding kinetics with purified recombinant Rab9\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro enzymatic characterization with purified recombinant protein and defined kinetic parameters\",\n      \"pmids\": [\"8463223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Cytosolic Rab9 exists as an equimolar complex with a GDI-like protein (~80 kDa). Complex formation requires intact Rab9 C-terminus and geranylgeranylation; monoprenylation is sufficient. Purified Rab3A-GDI can solubilize Rab9-GDP, but not Rab9-GTP, from cytoplasmic membranes, supporting a model in which GDI recycles Rab9 from target membranes after a catalytic transport cycle.\",\n      \"method\": \"In vitro reconstitution of GDI-Rab9 complex, geranylgeranylation assay, membrane extraction assay\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with recombinant proteins, C-terminal mutant controls, nucleotide-state specificity demonstrated\",\n      \"pmids\": [\"8389620\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Dominant-negative Rab9(S21N) expressed in living cells strongly inhibits MPR recycling to the TGN, reduces lysosomal enzyme sorting efficiency, and causes compensatory upregulation of lysosomal enzyme synthesis—demonstrating that Rab9 GTPase activity is required for MPR recycling and efficient lysosomal biogenesis in vivo.\",\n      \"method\": \"Dominant-negative mutant overexpression in cells, pulse-chase lysosomal enzyme sorting assay, fluid-phase and receptor-mediated endocytosis controls\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean dominant-negative loss-of-function with specific phenotypic readout and multiple controls ruling off-target effects; widely replicated\",\n      \"pmids\": [\"7909812\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Selective membrane targeting of prenylated Rab9 onto late endosome membranes is reconstituted in vitro and is accompanied by endosome-triggered nucleotide exchange (GDP→GTP). This establishes that late endosomes provide a guanine nucleotide exchange activity that activates Rab9 upon membrane delivery.\",\n      \"method\": \"In vitro membrane recruitment assay with prenylated Rab9-GDI complexes, nucleotide exchange measurement\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution of selective targeting with nucleotide exchange measurement; published in Nature with rigorous biochemical controls\",\n      \"pmids\": [\"8164745\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"GDI-bound Rab9 (Rab9-GDI complex) represents a functional cytosolic pool that supports late endosome-to-TGN transport in vitro. GDI increases the efficiency of Rab9 utilization by suppressing mistargeting; GDI itself inhibits transport by sequestering Rab9 from membranes. Rab7 and Rab9 use biochemically distinct recruitment machineries on late endosome membranes.\",\n      \"method\": \"Immunodepletion of cytosolic GDI-Rab9, reconstitution with purified Rab9-GDI, competitive inhibition experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — immunodepletion and reconstitution with purified components, competitive inhibition with defined Km/Ki values\",\n      \"pmids\": [\"8195183\", \"7592724\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"p40 (a 40 kDa protein) is a Rab9-GTP-preferential effector identified by yeast two-hybrid; it does not interact with Rab7 or K-Ras. Purified recombinant p40 potently stimulates MPR transport from endosomes to TGN in vitro, anti-p40 antibodies inhibit transport, and p40 shows synergy with Rab9—consistent with p40 and Rab9 acting together to drive transport vesicle docking.\",\n      \"method\": \"Yeast two-hybrid, GST pulldown, in vitro transport assay with recombinant p40, antibody inhibition\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (two-hybrid, pulldown, reconstituted transport, antibody inhibition) in one study\",\n      \"pmids\": [\"9230071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The cargo adaptor TIP47 binds directly to GTP-bound (active) Rab9 GTPase. Rab9-GTP binding increases the affinity of TIP47 for MPR cytoplasmic domains. A functional Rab9-binding site in TIP47 is required for TIP47 stimulation of MPR transport in vivo, establishing that Rab9 recruits TIP47 onto late endosomes and couples vesicle budding to active GTPase.\",\n      \"method\": \"Direct binding assay (in vitro), TIP47-MPR affinity measurement, dominant-negative Rab9 binding-site mutant rescue in cells\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro binding, quantitative affinity measurements, and functional validation in cells with binding-site mutant\",\n      \"pmids\": [\"11359012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"GFP-Rab9 localizes to late endosomes and occupies a distinct microdomain from Rab7 on the same late endosome membrane; CI-MPRs are enriched in the Rab9 domain. Live-cell video microscopy shows Rab9-positive transport vesicles (not tubules) fusing with the TGN; Rab9 remains vesicle-associated until membrane fusion and is rapidly removed upon docking/fusion.\",\n      \"method\": \"Live-cell fluorescence microscopy (GFP variants), video microscopy of vesicle fusion events\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — live imaging with direct visualization of fusion events; multiple fluorescent markers; widely cited\",\n      \"pmids\": [\"11827983\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"TIP47 residues 161–169 are essential (but not sufficient) for Rab9 binding. Mutation of these residues markedly decreases Rab9 binding without altering global protein folding or the ability of TIP47 to bind MPR cytoplasmic domains, demonstrating distinct binding domains for Rab9 and MPR in TIP47.\",\n      \"method\": \"Site-directed mutagenesis, binding assay, circular dichroism, partial proteolysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis with multiple orthogonal structural and functional validations\",\n      \"pmids\": [\"12032303\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The lipid kinase PIKfyve physically interacts with the Rab9 effector p40 via its chaperonin domain and p40's kelch repeats (determined by yeast two-hybrid, GST pulldown, and co-IP). Kinase-dead PIKfyve causes depletion of p40 from membrane fractions. PIKfyve phosphorylates p40 on serine in vitro, and this phosphorylation correlates with p40 membrane association, suggesting PIKfyve-catalyzed phosphorylation anchors p40 to membranes to facilitate late endosome-to-TGN transport.\",\n      \"method\": \"Yeast two-hybrid, GST pulldown, co-immunoprecipitation, differential centrifugation, in vitro kinase assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal binding methods plus in vitro kinase assay in one study\",\n      \"pmids\": [\"14530284\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Rab9 depletion by siRNA decreases late endosome size, reduces multilamellar and dense-tubule-containing late endosomes/lysosomes, causes perinuclear clustering of remaining organelles, and leads to increased surface MPRs and lysosome-associated membrane protein 1, with MPR missorting to lysosomes. Rab9 stability on late endosomes requires interaction with TIP47 (its effector), revealing that effector interaction maintains Rab membrane residence.\",\n      \"method\": \"siRNA knockdown, immunofluorescence, endosome morphology analysis, MPR trafficking assay\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KD with multiple defined phenotypic readouts and mechanistic follow-up on effector-dependent stability\",\n      \"pmids\": [\"15456905\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"BLOC-3 (HPS1-HPS4 heterodimer) interacts specifically and strongly with GTP-bound Rab9 via the HPS4 subunit engaging the switch I and II regions of Rab9, identifying BLOC-3 as a Rab9 effector.\",\n      \"method\": \"Recombinant protein co-expression in insect cells, analytical ultracentrifugation, GST pulldown interaction screen, deletion analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — recombinant reconstitution, analytical ultracentrifugation, and interaction mapping with switch-region specificity\",\n      \"pmids\": [\"20048159\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TIP47 is a key determinant of Rab9 localization: changing cellular concentrations of TIP47 (a Rab9 effector) can redirect Rab5/9 and Rab1/9 chimeras from their parental Rab localizations toward late endosomes. This demonstrates that effector concentrations compete to determine Rab localization.\",\n      \"method\": \"Chimeric Rab GTPase expression, effector binding quantification, live-cell localization assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — chimera approach with quantified effector binding and direct localization readout; multiple Rab chimeras tested\",\n      \"pmids\": [\"16769818\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Cholesterol accumulation in Niemann-Pick type C (NPC) cells elevates Rab9 protein levels (1.8-fold) by reducing its turnover and stabilizes Rab9 on endosome membranes, impairing GDI-mediated extraction. Cholesterol directly stabilizes prenylated Rab9 on liposomes in proportion to cholesterol content, sequestering Rab9 in an inactive form and disrupting CI-MPR recycling. Overexpression of GFP-Rab9 reverses MPR missorting in NPC cells.\",\n      \"method\": \"Western blot, half-life assay, GDI extraction assay, cholesterol-loaded liposome binding assay, siRNA knockdown to model NPC, GFP-Rab9 rescue\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — direct biochemical liposome assay plus cell biological assays with rescue experiment; multiple orthogonal methods\",\n      \"pmids\": [\"16644737\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RUTBC1 contains a TBC domain and binds specifically to Rab9A-GTP (in vitro and in cells) but is not a GAP for Rab9A. Instead, RUTBC1 is a GAP for Rab32 and Rab33B (requiring Arg-803 as the catalytic arginine finger, consistent with a dual-finger mechanism). Rab9A binding does not influence RUTBC1 GAP activity, but RUTBC1 influences Rab32's ability to bind its effector Varp, consistent with RUTBC1 linking Rab9A and Rab32 in adjacent pathways at late endosomes.\",\n      \"method\": \"In vitro GTP hydrolysis screen of Rab substrates, site-directed mutagenesis of catalytic Arg, co-immunoprecipitation, cell extract effector-binding assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — biochemical screen with mutagenesis, catalytic mechanism tested, cellular validation with effector-binding assay\",\n      \"pmids\": [\"21808068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Furin transits early and late endosomes en route to the TGN and requires Rab9 and the golgin GCC185 for efficient TGN retrieval from late endosomes. TGN38 trafficking is independent of Rab9. Furin-TGN38 chimera experiments show that both the transmembrane domain and cytoplasmic tail of TGN38 are required to divert furin from the Rab9-dependent late endosome pathway to the retromer-dependent early endosome pathway; transmembrane domain length contributes to endosomal sorting.\",\n      \"method\": \"Internalization assay, dominant-negative Rab9, siRNA knockdown of GCC185, chimeric protein expression\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two orthogonal loss-of-function approaches (dominant-negative and siRNA) with chimera dissection in single lab\",\n      \"pmids\": [\"21693586\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"RUTBC2 (TBC domain protein) binds Rab9A-GTP specifically in vitro and in cells but is not a GAP for Rab9A. RUTBC2 is a GAP for Rab34 and Rab36 (highest activity toward Rab36), requiring Arg-829 for catalysis. In cells, RUTBC2 co-localizes with Rab36 and decreases membrane-associated Rab36, linking Rab9A function to Rab36 in the endosomal system.\",\n      \"method\": \"Rab substrate GAP screen in vitro, site-directed mutagenesis, co-immunoprecipitation, co-localization, membrane fractionation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — biochemical GAP screen, catalytic mutagenesis, and cellular validation with membrane fractionation\",\n      \"pmids\": [\"22637480\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In Drosophila trachea, Rab9 together with retromer (Vps35) and WASH regulates selective retrograde recycling of the luminal protein Serpentine from late endosomes. Vps35, WASH, and actin filaments differentially localize to Rab9-enriched subdomains of the endosomal membrane, where Serpentine-containing vesicles bud. Loss of Rab9, Vps35, or WASH depletes luminal Serpentine at later stages (without affecting initial secretion), causing excessively elongated tubes.\",\n      \"method\": \"Genetic mutant analysis (Rab9, Vps35, WASH loss-of-function in Drosophila), immunofluorescence co-localization, tube length phenotype quantification\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple independent genetic mutants with specific phenotypic readout and protein co-localization in Drosophila\",\n      \"pmids\": [\"23322046\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Live-cell imaging shows Rab9 constitutively active mutant (Rab9Q66L) localizes predominantly to late endosomes and disperses TGN46 and CI-MPR from the Golgi, but does not block retrograde transport of CI-MPR. Rab9 and CI-MPR enter the endosomal pathway together at the early-to-late endosome transition stage (between Rab5-positive and Rab7a-positive compartments); CI-MPR-containing vesicles attach and detach within seconds from distinct endosomal domains.\",\n      \"method\": \"Confocal live-cell imaging, constitutively active mutant expression (Rab9Q66L), co-localization with Rab5/Rab7a markers\",\n      \"journal\": \"Traffic\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — live imaging with constitutively active mutant, single lab, two orthogonal approaches\",\n      \"pmids\": [\"26663757\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"During myocardial ischemia, mitophagy is mediated predominantly by Rab9-associated autophagosomes rather than the canonical ATG7/LC3 conjugation system. A protein complex of Ulk1, Rab9, Rip1, and Drp1 mediates recruitment of trans-Golgi membranes to damaged mitochondria. Ulk1 phosphorylates Rab9 at Ser179; knockin of Rab9(S179A) abolishes this alternative mitophagy and exacerbates ischemic injury without affecting conventional autophagy.\",\n      \"method\": \"Co-immunoprecipitation, knockin mouse (Rab9 S179A), cardiac ischemia model, mitophagy flux assay, ATG7-deficient controls\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — knockin mouse with phospho-site mutation, co-IP of complex, multiple pathway controls (ATG7-deficient); in vivo ischemia model\",\n      \"pmids\": [\"30511961\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Rab9 interacts with the intermediate filament protein vimentin. In NPC1 cells, lipid accumulation inhibits PKC, causing hypophosphorylation of vimentin, which leads to vimentin aggregation and Rab9 entrapment within the aggregates, thereby disrupting late endosome function and lipid egress.\",\n      \"method\": \"Co-immunoprecipitation, PKC inhibition assay, vimentin phosphorylation analysis, Rab9-vimentin interaction assay in NPC1 cells\",\n      \"journal\": \"Biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — co-IP and mechanistic follow-up in NPC1 cells, single lab\",\n      \"pmids\": [\"18681838\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Rab9 co-localizes in vesicular structures with TRPC6 and co-immunoprecipitates with TRPC6. Dominant-negative Rab9(S21N) increases TRPC6 at the plasma membrane and augments TRPC6-mediated Ca²⁺ entry upon muscarinic stimulation, demonstrating that Rab9-dependent late endosomal trafficking regulates TRPC6 surface density.\",\n      \"method\": \"Co-immunoprecipitation, confocal co-localization, dominant-negative Rab9 expression, Ca²⁺ imaging\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — co-IP plus functional dominant-negative phenotype; single lab, single study\",\n      \"pmids\": [\"20346379\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Nde1 (and its paralog Ndel1) is a Rab9A effector: GTP-bound Rab9A specifically interacts with Nde1/Ndel1 to link late endosomes to the cytoplasmic dynein motor complex. Crystal structure of Rab9A-GTP bound to the Rab9-binding region of Nde1 was determined. Key interface residues verified by mutagenesis; Rab9A mutants unable to bind Nde1 failed to associate with dynein, Lis1, and dynactin, establishing Nde1 as the tether between Rab9-positive late endosomes and dynein for retrograde transport.\",\n      \"method\": \"Crystal structure determination, biochemical pulldown, mutagenesis of interface residues, co-immunoprecipitation in cells\",\n      \"journal\": \"Structure\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with functional validation by mutagenesis and cell biology assays\",\n      \"pmids\": [\"34793709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"In asthma, IL-4 activates a ULK1/Atg9a/Rab9 signaling cascade: ULK1 phosphorylates Atg9a at Ser14; Atg9a is a superior upstream regulator of Rab9; and Rab9 plays a role in inflammation-induced Golgi apparatus fragmentation. Inhibition of ULK1/Atg9a/Rab9 reduces Golgi fragmentation and mitochondrial oxidative stress.\",\n      \"method\": \"ULK1 knockout mice, lentiviral overexpression of ULK1 WT and S467A mutant in Beas-2b cells, co-IP (ULK1-Atg9a), phosphorylation site mutagenesis\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO plus phospho-site mutagenesis in cells; single lab, Rab9-specific evidence is downstream/indirect\",\n      \"pmids\": [\"38373380\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"NDP52 forms a complex with Rab9 and HBV envelope proteins and links HBV to a Rab9-dependent lysosomal degradation pathway. This process is independent of galectin-8 and ATG5. Inactivating NDP52 reduces targeting of viral envelopes to lysosomes and increases viral replication levels.\",\n      \"method\": \"Co-immunoprecipitation (NDP52-Rab9-HBV envelope), NDP52 knockdown in hepatocytes, ATG5-independent pathway controls\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP with three-component complex, knockdown phenotype, pathway controls; single lab\",\n      \"pmids\": [\"38114531\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Rab9a in its GTP-bound form inhibits (rather than promotes) retromer-mediated endosomal exit of HPV during virus entry. Rab9a knockdown impairs retromer-mediated endosome-to-Golgi transport of HPV and causes HPV accumulation in endosomes. Excess GTP-Rab9a impairs HPV entry, whereas excess GDP-Rab9a reduces L2-Rab9a association and stimulates entry—a noncanonical action opposite to Rab9a's role for cellular cargo.\",\n      \"method\": \"siRNA knockdown, dominant-negative and constitutively active Rab9a overexpression, proximity ligation assay (Rab9a-HPV), retromer interaction assay\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple Rab9a mutants plus knockdown with specific phenotypic and interaction readouts; single lab\",\n      \"pmids\": [\"37703297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TMEM9, a lysosomal transmembrane protein, interacts with Beclin1 via its Bcl-2-binding domain to activate Rab9-dependent alternative autophagy. TMEM9-Beclin1 interaction dissociates Bcl-2 from Beclin1, enabling LC3-independent, Rab9-dependent autophagosome formation. TMEM9 colocalizes with Rab9 on late endosomes/lysosomes. Multiple glycosylation of TMEM9 (required for lysosomal localization) is essential for Beclin1 binding and Rab9-dependent autophagy activation.\",\n      \"method\": \"Co-immunoprecipitation (TMEM9-Beclin1), Bcl-2 dissociation assay, TMEM9 glycosylation mutants, autophagy flux assay, co-localization\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP with domain mapping, glycosylation mutant functional validation, autophagy readout; single lab\",\n      \"pmids\": [\"39078420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"GDP-bound Rab9a has an extremely short half-life compared with GTP-bound Rab9a and compared with the closely related Rab7. Hydrophobic residues exposed in the switch I region of GDP-Rab9a constitute a conformation-dependent hydrophobic (CDH) degron recognized by the protein quality control (PQC) machinery including valosin-containing protein/p97. CDH degron-mutated Rab9a accumulates in cells and causes defective CI-M6PR localization; forced accumulation phenocopies PQC dysfunction.\",\n      \"method\": \"Half-life measurement, site-directed mutagenesis of switch I hydrophobic residues, CI-M6PR localization assay, identification of p97 as CDH degron reader\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — mutagenesis with functional readout and identification of PQC factor; single lab, recent publication\",\n      \"pmids\": [\"41628772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Pharmacological PKC activation promotes α1B-adrenergic receptor transfer to late endosomes (Rab9-positive compartment) following early endosome transit (Rab5). Dominant-negative Rab9-GDP abolishes receptor traffic to late endosomes, alters desensitization of the calcium response, and suppresses receptor internalization, identifying Rab9-mediated late endosome trafficking as a component of heterologous adrenergic receptor desensitization.\",\n      \"method\": \"FRET (DsRed-α1B-AR / EGFP-Rab proteins), confocal microscopy, dominant-negative Rab9 expression, intracellular Ca²⁺ quantitation, PKC inhibitors\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — FRET-based interaction in live cells plus functional Ca²⁺ readout with dominant-negative validation; single lab\",\n      \"pmids\": [\"28082304\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HPS4 Rab32/38-GEF activity (not its Rab9-binding activity) is essential for melanogenesis in HPS4-deficient melanocytes. Re-expression of an HPS4 mutant specifically lacking Rab9-binding activity fully rescues pigmentation and tyrosinase trafficking, whereas Rab32/38-GEF-deficient HPS4 fails to rescue. This demonstrates that the Rab9-BLOC-3 interaction is dispensable for melanogenesis.\",\n      \"method\": \"Site-directed mutagenesis of HPS4 (separate Rab32/38-GEF-null and Rab9-binding-null mutants), rescue assay in melan-le HPS4-deficient melanocytes, melanin content and tyrosinase trafficking assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — separation-of-function mutagenesis with two distinct mutants, clean rescue assay in disease-relevant cell line\",\n      \"pmids\": [\"30837268\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"RAB9 protein levels increase significantly in aged (old) oocytes in humans and mice. RAB9 localizes to the meiotic spindle periphery and cortex. Rab9 overexpression disrupts spindle formation, chromosome alignment, actin cap formation, cortical actin levels, increases ROS, decreases mitochondrial membrane potential and ATP, and activates PINK1-PARKIN mitophagy. Reducing RAB9 expression in old oocytes partially improves maturation rate, reduces ROS and spindle abnormalities.\",\n      \"method\": \"Immunofluorescence (localization in oocytes), Rab9 overexpression and knockdown, mitochondrial function assays, ROS measurement, PINK1/PARKIN pathway analysis\",\n      \"journal\": \"Aging cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function with multiple quantitative readouts in oocytes; single lab, single study\",\n      \"pmids\": [\"39676221\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RAB9A is a late-endosomal Rab GTPase that, in its active GTP-bound state, recruits the cargo adaptor TIP47 (with enhanced affinity for MPR cytoplasmic tails) and the effector p40 onto a distinct subdomain of late endosomes to drive transport vesicle budding and docking at the TGN for recycling of mannose 6-phosphate receptors; GDI delivers prenylated Rab9-GDP to late endosomes where nucleotide exchange activates it, and after fusion, GDI extracts Rab9-GDP for cytosolic recycling. Additional effectors include Nde1/Ndel1 (tethering Rab9-positive late endosomes to the dynein motor for retrograde transport), RUTBC1 (a Rab9A-GTP-binding Rab32/33B-GAP linking Rab9A to lysosome-related organelle pathways), RUTBC2 (a Rab9A-GTP-binding Rab36-GAP), and BLOC-3/HPS4 (whose Rab9 interaction is dispensable for melanogenesis). A functionally distinct role has been established in alternative (non-canonical, ATG7/LC3-independent) autophagy: a complex of Ulk1, Rab9, Rip1, and Drp1 mediates mitophagy through Ulk1 phosphorylation of Rab9 at Ser179, which recruits trans-Golgi membranes to damaged mitochondria, and this pathway is cardioprotective under ischemia. GDP-bound Rab9a is rapidly degraded via a conformation-dependent hydrophobic degron in its switch I region recognized by p97/VCP quality-control machinery, ensuring proper CI-M6PR trafficking.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"RAB9A is a late-endosomal Rab GTPase that drives retrograde recycling of mannose 6-phosphate receptors (MPRs) from late endosomes to the trans-Golgi network, a transport step required for efficient lysosomal enzyme sorting and lysosomal biogenesis [#0, #3]. Cycling between GDP- and GTP-bound states (with defined intrinsic hydrolysis and nucleotide-exchange kinetics) governs its activity [#1]: GDI delivers prenylated Rab9-GDP to late endosomes, where an endosome-associated exchange activity converts it to the active GTP form and GDI then extracts Rab9-GDP for cytosolic recycling [#2, #4, #5]. On late endosomes Rab9 occupies a distinct microdomain separate from Rab7, enriched in CI-MPR, from which Rab9-positive vesicles bud and fuse with the TGN [#8]. In its GTP-bound state Rab9 recruits a set of effectors that execute transport: the cargo adaptor TIP47, whose Rab9 binding enhances its affinity for MPR cytoplasmic tails and couples cargo capture to the active GTPase, and the effector p40, which synergizes with Rab9 to stimulate transport and is anchored to membranes by PIKfyve-catalyzed phosphorylation [#6, #7, #9, #10]; effector occupancy in turn stabilizes Rab9 on the membrane and dictates its localization [#11, #13]. Additional GTP-dependent effectors connect Rab9 to other organelle pathways and the cytoskeleton: Nde1/Ndel1 tethers Rab9-positive late endosomes to the dynein motor for retrograde transport (defined by crystal structure) [#23], while the TBC-domain proteins RUTBC1 and RUTBC2 bind Rab9A-GTP yet act as GAPs for Rab32/Rab33B and Rab34/Rab36 respectively, linking Rab9 to adjacent Rab pathways [#15, #17]. BLOC-3 (HPS1-HPS4) is a GTP-dependent Rab9 effector, but this interaction is dispensable for melanogenesis [#12, #30]. Distinct from its trafficking role, Rab9 mediates an ATG7/LC3-independent alternative autophagy in which a Ulk1-Rab9-Rip1-Drp1 complex, dependent on Ulk1 phosphorylation of Rab9 at Ser179, recruits trans-Golgi membranes to damaged mitochondria and is cardioprotective during ischemia [#20]. Rab9 dysfunction is mechanistically tied to Niemann-Pick type C, where cholesterol stabilizes inactive Rab9 on membranes and impairs MPR recycling [#14]. The GDP-bound state is intrinsically unstable, exposing a conformation-dependent hydrophobic degron in switch I recognized by the p97/VCP quality-control machinery, which couples Rab9a turnover to correct CI-M6PR trafficking [#28].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Established Rab9 as a functionally specific, prenylation-dependent regulator of late endosome-to-TGN transport of MPRs, distinct from the co-resident Rab7.\",\n      \"evidence\": \"Cell-free transport reconstitution with prenylated recombinant Rab9, C-terminal truncation mutant, and Rab7 specificity control\",\n      \"pmids\": [\"8440258\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Effectors mediating the transport step not yet identified\", \"Mechanism of selective late-endosome targeting unresolved\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Defined the intrinsic enzymatic parameters of Rab9, quantifying its slow GTP hydrolysis and nucleotide exchange rates as the kinetic basis for its GTPase switch.\",\n      \"evidence\": \"In vitro GTP hydrolysis and nucleotide binding kinetics with purified recombinant Rab9\",\n      \"pmids\": [\"8463223\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No GAP or GEF identified at this stage\", \"Does not connect kinetics to in vivo regulation\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Showed Rab9 cycles through a cytosolic GDI-bound, GDP-state pool, defining how the prenylated GTPase is solubilized and recycled in a nucleotide-state-dependent manner.\",\n      \"evidence\": \"In vitro reconstitution of GDI-Rab9 complex with geranylgeranylation and membrane extraction assays\",\n      \"pmids\": [\"8389620\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the membrane GEF not established\", \"Spatial coupling of extraction to transport cycle not resolved\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Demonstrated in living cells that Rab9 GTPase activity is required for MPR recycling and lysosomal biogenesis, validating in vitro findings physiologically.\",\n      \"evidence\": \"Dominant-negative Rab9(S21N) overexpression with pulse-chase lysosomal enzyme sorting assays\",\n      \"pmids\": [\"7909812\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Dominant-negative may sequester shared GEFs\", \"Direct effectors still unknown\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Resolved the activation and recruitment cycle by showing late endosomes provide GEF activity that activates GDI-delivered Rab9 upon selective membrane targeting.\",\n      \"evidence\": \"In vitro reconstitution of prenylated Rab9-GDI membrane recruitment with nucleotide exchange measurement; immunodepletion/reconstitution of cytosolic GDI-Rab9\",\n      \"pmids\": [\"8164745\", \"8195183\", \"7592724\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular identity of the late-endosomal GEF not determined\", \"Determinants of Rab9-vs-Rab7 recruitment specificity not defined\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Identified p40 as the first GTP-preferential Rab9 effector that synergizes with Rab9 to drive transport vesicle docking.\",\n      \"evidence\": \"Yeast two-hybrid, GST pulldown, reconstituted transport assay, and antibody inhibition with recombinant p40\",\n      \"pmids\": [\"9230071\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Membrane recruitment mechanism of p40 not yet defined\", \"Structural basis of Rab9-p40 interaction unknown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Established the cargo-coupling mechanism: Rab9-GTP recruits TIP47 and increases its affinity for MPR tails, linking active GTPase to cargo capture and vesicle budding.\",\n      \"evidence\": \"Direct in vitro binding, TIP47-MPR affinity measurement, and Rab9-binding-site mutant rescue in cells\",\n      \"pmids\": [\"11359012\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Coordination between TIP47 and p40 not resolved\", \"Structural details of the Rab9-TIP47 interface not yet defined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Mapped the discrete TIP47 region required for Rab9 binding and showed it is separate from the MPR-binding domain, defining bipartite cargo-adaptor architecture.\",\n      \"evidence\": \"Site-directed mutagenesis with circular dichroism and partial proteolysis controls\",\n      \"pmids\": [\"12032303\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Residues necessary but not sufficient — full binding determinants incomplete\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Visualized Rab9 as a discrete late-endosome microdomain enriched in CI-MPR from which transport vesicles bud and fuse with the TGN, defining the spatial organization of the pathway.\",\n      \"evidence\": \"Live-cell and video fluorescence microscopy with GFP-Rab9 and multiple markers\",\n      \"pmids\": [\"11827983\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism establishing the Rab9/Rab7 domain boundary unknown\", \"Fusion machinery at the TGN not defined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Connected lipid kinase signaling to the pathway by showing PIKfyve phosphorylates the effector p40 to anchor it to membranes.\",\n      \"evidence\": \"Yeast two-hybrid, GST pulldown, co-IP, fractionation, and in vitro kinase assay with kinase-dead PIKfyve\",\n      \"pmids\": [\"14530284\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphosite on p40 not mapped\", \"Direct effect on Rab9 itself not demonstrated\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Showed effector binding reciprocally stabilizes Rab9 on membranes and defined the cellular consequences of Rab9 loss for endosome morphology and MPR sorting.\",\n      \"evidence\": \"siRNA knockdown with endosome morphology and MPR trafficking readouts\",\n      \"pmids\": [\"15456905\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which TIP47 stabilizes Rab9 not biochemically defined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Expanded the Rab9 effector repertoire to BLOC-3 and demonstrated that effector concentration competes to determine Rab9 subcellular localization.\",\n      \"evidence\": \"Recombinant reconstitution, analytical ultracentrifugation, switch-region mapping; Rab chimera localization with quantified effector binding\",\n      \"pmids\": [\"20048159\", \"16769818\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional role of Rab9-BLOC-3 interaction not yet defined\", \"How competing effectors are spatially regulated unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Provided a mechanistic link between Rab9 and Niemann-Pick type C, showing cholesterol stabilizes inactive Rab9 and impairs MPR recycling, reversible by Rab9 overexpression.\",\n      \"evidence\": \"Half-life and GDI-extraction assays, cholesterol-loaded liposome binding, NPC siRNA model, GFP-Rab9 rescue\",\n      \"pmids\": [\"16644737\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular interaction of cholesterol with Rab9 not structurally defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Linked Rab9 to the cytoskeleton via vimentin and proposed a route by which lipid accumulation entraps Rab9 in NPC1 cells.\",\n      \"evidence\": \"Co-IP, PKC inhibition, vimentin phosphorylation analysis in NPC1 cells\",\n      \"pmids\": [\"18681838\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab co-IP without structural mapping\", \"Functional consequence of Rab9-vimentin binding for normal trafficking unclear\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Extended Rab9-dependent late-endosomal trafficking to control of a plasma-membrane channel, TRPC6, and downstream Ca2+ entry.\",\n      \"evidence\": \"Co-IP, co-localization, dominant-negative Rab9, Ca2+ imaging\",\n      \"pmids\": [\"20346379\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single study\", \"Direct vs indirect Rab9-TRPC6 interaction not resolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identified RUTBC1 as a Rab9A-GTP-binding TBC protein that is a GAP not for Rab9 but for Rab32/Rab33B, positioning Rab9A as an organizer linking adjacent Rab pathways at late endosomes.\",\n      \"evidence\": \"In vitro GAP substrate screen, catalytic Arg mutagenesis, co-IP, effector-binding assay\",\n      \"pmids\": [\"21808068\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Biological significance of Rab9A-RUTBC1 coupling in cells not fully established\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined cargo specificity of the Rab9 pathway by showing furin requires Rab9 and GCC185 for TGN retrieval whereas TGN38 does not, mapping the determinants that route cargo into the Rab9-dependent route.\",\n      \"evidence\": \"Dominant-negative Rab9, GCC185 siRNA, furin-TGN38 chimera dissection\",\n      \"pmids\": [\"21693586\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study\", \"Sorting determinant mechanism only partially resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified RUTBC2 as a second Rab9A-GTP-binding TBC protein acting as a GAP for Rab34/Rab36, reinforcing Rab9A as a hub connecting distinct Rab modules.\",\n      \"evidence\": \"In vitro GAP screen, catalytic mutagenesis, co-IP, co-localization, membrane fractionation\",\n      \"pmids\": [\"22637480\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological pathway connecting Rab9A and Rab36 not defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Showed in vivo (Drosophila) that Rab9 cooperates with retromer and WASH at endosomal subdomains for selective retrograde recycling, broadening its role beyond MPRs.\",\n      \"evidence\": \"Genetic loss-of-function of Rab9, Vps35, WASH; co-localization; tube-length phenotypes\",\n      \"pmids\": [\"23322046\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct biochemical link between Rab9 and retromer/WASH not established\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Refined the timing of Rab9/CI-MPR entry into the endosomal pathway and showed constitutively active Rab9 disperses TGN markers without blocking retrograde transport.\",\n      \"evidence\": \"Confocal live-cell imaging with Rab9Q66L and Rab5/Rab7a co-localization\",\n      \"pmids\": [\"26663757\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Mechanism of TGN marker dispersal unresolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Implicated Rab9-dependent late-endosomal trafficking in heterologous desensitization of the α1B-adrenergic receptor.\",\n      \"evidence\": \"FRET, confocal microscopy, dominant-negative Rab9, Ca2+ quantitation, PKC inhibitors\",\n      \"pmids\": [\"28082304\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single study\", \"Direct Rab9-receptor interaction not demonstrated\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established a distinct, non-canonical function for Rab9 in ATG7/LC3-independent alternative mitophagy via a Ulk1-Rab9-Rip1-Drp1 complex driven by Ser179 phosphorylation, with cardioprotective consequences.\",\n      \"evidence\": \"Co-IP, Rab9(S179A) knockin mouse, cardiac ischemia model, ATG7-deficient controls\",\n      \"pmids\": [\"30511961\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How phospho-Rab9 recruits trans-Golgi membranes mechanistically unclear\", \"Relationship to canonical Rab9 trafficking function not resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Separated the GEF and Rab9-binding functions of HPS4, demonstrating that the Rab9-BLOC-3 interaction is dispensable for melanogenesis.\",\n      \"evidence\": \"Separation-of-function HPS4 mutants, rescue in HPS4-deficient melanocytes, melanin/tyrosinase readouts\",\n      \"pmids\": [\"30837268\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological role of the Rab9-BLOC-3 interaction remains undefined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Determined the structural and functional basis for Rab9A coupling to retrograde dynein transport via the effector Nde1/Ndel1.\",\n      \"evidence\": \"Crystal structure of Rab9A-GTP:Nde1, interface mutagenesis, co-IP showing loss of dynein/Lis1/dynactin association\",\n      \"pmids\": [\"34793709\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Coordination of Nde1 tethering with budding/fusion not defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Placed Rab9 downstream of a ULK1/Atg9a cascade in inflammation-induced Golgi fragmentation in asthma.\",\n      \"evidence\": \"ULK1 KO mice, ULK1 WT/S467A overexpression, ULK1-Atg9a co-IP, phosphosite mutagenesis\",\n      \"pmids\": [\"38373380\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Rab9-specific evidence is downstream/indirect\", \"Direct Rab9 regulatory mechanism not established\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Revealed roles for Rab9 in host-pathogen interactions: NDP52-Rab9 directs HBV envelopes to lysosomal degradation, while Rab9a-GTP non-canonically inhibits retromer-mediated HPV endosomal exit.\",\n      \"evidence\": \"Co-IP of NDP52-Rab9-HBV envelope with knockdown; siRNA, dominant-negative/constitutively active Rab9a, PLA, retromer interaction assays for HPV\",\n      \"pmids\": [\"38114531\", \"37703297\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab studies\", \"Whether Rab9 directly binds viral components not resolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified TMEM9 as an activator of Rab9-dependent alternative autophagy through Beclin1 engagement and Bcl-2 displacement.\",\n      \"evidence\": \"Co-IP, Bcl-2 dissociation assay, TMEM9 glycosylation mutants, autophagy flux, co-localization\",\n      \"pmids\": [\"39078420\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Direct Rab9-TMEM9 functional coupling not biochemically defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Linked elevated RAB9 to oocyte aging, where its overexpression disrupts spindle/actin organization and triggers PINK1-PARKIN mitophagy and oxidative stress.\",\n      \"evidence\": \"Immunofluorescence localization, Rab9 gain/loss-of-function, mitochondrial and ROS assays in human and mouse oocytes\",\n      \"pmids\": [\"39676221\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single study\", \"Causal mechanism connecting Rab9 to spindle/actin defects unresolved\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Showed that the GDP-bound state of Rab9a is intrinsically unstable due to a switch-I conformation-dependent hydrophobic degron read by p97/VCP, coupling Rab9a turnover to correct CI-M6PR trafficking.\",\n      \"evidence\": \"Half-life measurement, switch-I hydrophobic-residue mutagenesis, CI-M6PR localization assay, identification of p97 as degron reader\",\n      \"pmids\": [\"41628772\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab, recent\", \"Full PQC machinery beyond p97 not defined\", \"How degron sensing is balanced against GDI extraction unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How Rab9 partitions between its canonical retrograde trafficking role and its non-canonical alternative-autophagy/host-defense roles, and what GEF activates it on late endosomes, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular identity of the late-endosomal Rab9 GEF unknown\", \"Switch between trafficking and alternative-autophagy effector complexes not defined\", \"Structural basis of phospho-Ser179 effector recruitment unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [1, 3]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [7, 11, 15, 17]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [0, 8, 11, 19]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2, 5]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [8, 16]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [0, 3, 7, 8]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [6, 23]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [20, 27]}\n    ],\n    \"complexes\": [\"Ulk1-Rab9-Rip1-Drp1 alternative-autophagy complex\", \"BLOC-3 (HPS1-HPS4) effector complex\"],\n    \"partners\": [\"TIP47\", \"p40\", \"Nde1\", \"Ndel1\", \"RUTBC1\", \"RUTBC2\", \"HPS4\", \"Ulk1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}